About this trial
The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital.
The main question\[s\] it aims to answer are:
* How much time and what resources are needed to run such a program * How well do patients follow up with the phone calls, bloodwork, and doctor appointments? * Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program?
Participants will
* Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital * Receive a phone call from the study team within 72 hours of discharge and weekly * Be given a follow up appointment with hepatology within 4 weeks of discharge
Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients > 18 years of age.
Inpatient at Penn State Health, Milton S. Hershey Medical Center.
Diagnosis of cirrhosis.
Hospitalized with fluid overload (ascites and/or significant anasarca/edema) requiring diuretic therapy.
Disqualifiers
Placement of a TIPS.
Ascites from an etiology other than cirrhosis, such as malignancy, heart failure, pancreatitis, nephrotic syndrome.
Non-English speaking
Trial design
Parallel
Treatments tested in this trial
Transitional Care Program
BehavioralIntensive monitoring post discharge for cirrhosis and fluid overload
Treatment groups
Trial outcomes
Primary outcomes
feasibility of the program
how much time does it take to review material and complete phone calls
Number of instances of weight monitoring
at home monitoring weight
Number of successful phone calls
weekly phone call with participant
Number of follow up visits
lab visits, primary care visits, hepatology visits
Secondary outcomes
Number of Hospitalizations per participant
number of admissions to the hospital
Number of subjects that develop Acute Kidney Injury
Creatinine increase of \>0.3g/dL
Number of subjects that continue to have volume overload
persistent weight above dry weight and/or ongoing ascites/lower extremity edema/pleural effusion
Number of subjects that expire
subject death
Sponsors and contacts
Click on the lead sponsor to view all of their trials.